Reduced-Intensity Allogeneic Transplantation Provides High Event-Free and Overall Survival in Patients with Advanced Indolent B Cell Malignancies: CALGB 109901-Reference-Cited by-同舟云学术

Reduced-Intensity Allogeneic Transplantation Provides High Event-Free and Overall Survival in Patients with Advanced Indolent B Cell Malignancies: CALGB 109901

Published:2011-09 Issue:9 Volume:17 Page:1395-1403
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Shea Thomas,Johnson Jeffrey,Westervelt Peter,Farag Sherif,McCarty John,Bashey Asad,Isola Luis,Baxter-Lowe Lee-Anne,Kelly Michael,Owzar Kouros,Linker Charles

Funder

Amgen, Inc.

National Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference51 articles.

1. Improved survival of follicular lymphoma patients in the United States;Swenson;J Clin Oncol,2005

2. New treatment options have changed the survival of patients with follicular lymphoma;Fisher;J Clin Oncol,2005

3. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia;Tam;Blood,2008

4. Mature results of the M.D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma;Tam;Blood,2009

5. Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909;Damon;J Clin Oncol,2009

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced‐intensity conditioning with fludarabine/busulfan versus fludarabine/low‐dose melphalan in patients with non‐Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation;British Journal of Haematology;2024-07-24

2. Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

3. Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary Central Nervous System Lymphoma;Transplantation and Cellular Therapy;2021-10

4. The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis;Bone Marrow Transplantation;2020-06-18

5. Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience;Bone Marrow Transplantation;2019-09-03